Psoriasis: Symptoms, Causes, Types, and Treatment — What Your Family Doctor Wants You to Know in 2026

Psoriasis is a chronic autoimmune disease that causes the immune system to accelerate skin cell growth, leading to thick, scaly patches on the skin. It affects about 3% of U.S. adults, is not contagious, and can usually be managed with topical medications, phototherapy, oral drugs, or biologic therapies depending on severity.

Right now, somewhere beneath the surface of your skin, your immune system may be waging a quiet war against your own body. In psoriasis, that war becomes visible: your skin cells multiply up to ten times faster than normal, piling up into thick, scaly patches that itch, crack, and sometimes bleed. Approximately 7.5 million American adults — about 3% of the U.S. population — live with psoriasis, making it one of the most common immune-mediated skin conditions in the country. Yet most people with psoriasis wait years before getting an accurate diagnosis, and many never learn that the symptoms go far deeper than skin.

Psoriasis is not just a rash. It is a chronic, systemic inflammatory disease linked to cardiovascular disease, metabolic syndrome, depression, and joint destruction. The good news: treatment has never been better. From topical therapies your family doctor can prescribe today to the first-ever oral IL-23 inhibitor approved by the FDA in March 2026, the options for achieving clear or nearly clear skin are expanding rapidly. And much of psoriasis management — including diagnosis, medication adjustments, and mental health screening — can happen over a telehealth visit from home.

Quick Summary: Key Facts at a Glance

What Is Psoriasis?

Psoriasis is a chronic, immune-mediated autoimmune skin condition that primarily affects the skin but can involve the joints, nails, and multiple organ systems. In a healthy person, skin cells grow deep in the skin and slowly rise to the surface over about a month, then shed. In psoriasis, the immune system sends faulty signals that accelerate this process dramatically — new skin cells reach the surface in just three to four days. Because the body cannot shed cells that quickly, they pile up into the thick, raised patches called plaques.

The condition is driven by an overactive immune response, specifically involving T cells and inflammatory proteins called cytokines — most notably interleukin-17 (IL-17) and interleukin-23 (IL-23). This is not a hygiene issue, it is not an allergy, and it is absolutely not contagious. You cannot catch psoriasis from touching someone, sharing a pool, or any form of contact.

Psoriasis tends to follow a relapsing-remitting course, meaning symptoms may flare for weeks or months and then improve or even disappear temporarily. However, the underlying immune dysfunction remains, which is why ongoing management matters.

Types of Psoriasis

Psoriasis presents in several distinct forms. Understanding which type you have helps guide treatment.

Plaque psoriasis is by far the most common form, accounting for approximately 80–90% of cases. It appears as well-defined, raised, red patches covered with silvery-white scales, most often on the elbows, knees, scalp, and lower back. On darker skin tones, plaques may appear more purple or dark brown with gray scales rather than the classic red-and-silver presentation often shown in textbooks.

Guttate psoriasis accounts for about 8% of cases and appears as small, drop-shaped lesions scattered across the trunk, arms, and legs. It is frequently triggered by a streptococcal throat infection and is the most common form in children and young adults.

Inverse psoriasis develops in skin folds — the armpits, groin, under the breasts, and between the buttocks. It appears as smooth, shiny, red patches without the typical scaling, which can make it easy to mistake for a fungal infection.

Pustular psoriasis presents with pus-filled blisters (not infected — the pus contains white blood cells) surrounded by red skin. It can be localized to the hands and feet or, in rare cases, cover large areas of the body.

Erythrodermic psoriasis is the rarest and most serious form, involving widespread redness and shedding of skin over most of the body. It can be life-threatening and requires emergency medical care.

Nail psoriasis affects up to 50% of people with skin psoriasis and can cause pitting, discoloration, thickening, and separation of the nail from the nail bed (onycholysis).

Scalp psoriasis is one of the most common locations, affecting about 45–56% of patients. It ranges from mild, fine scaling to thick, crusted plaques covering the entire scalp and extending beyond the hairline. It is often confused with dandruff or seborrheic dermatitis — the key difference is that psoriasis plaques are typically thicker, more sharply defined, and silvery-white rather than yellowish.

Psoriasis vs. Eczema: How to Tell the Difference

Because psoriasis and eczema are both chronic skin conditions that cause red, inflamed patches, patients often confuse them. Here is how they differ:

For more on eczema specifically, see our eczema in adults guide.

What Causes Psoriasis?

Psoriasis results from a combination of genetic predisposition and environmental triggers. You do not simply "catch" psoriasis — your immune system must be genetically primed for it, and then something activates that predisposition.

Genetics play a significant role. About one-third of people with psoriasis have a first-degree relative with the condition. The strongest genetic association is with the PSORS1 locus on chromosome 6, which is part of the major histocompatibility complex (MHC) — the same region involved in many autoimmune diseases.

The immune system is the engine. Psoriasis is driven by the IL-23/IL-17 axis: dendritic cells produce IL-23, which activates a subset of T cells (Th17 cells) that release IL-17. IL-17 then triggers keratinocytes (skin cells) to proliferate rapidly and recruit more inflammatory cells, creating a self-perpetuating cycle of inflammation.

Common Psoriasis Triggers

While genetics load the gun, triggers pull it. Research shows that more than 70% of patients report specific events or exposures that precede a flare. Common triggers include:

Stress is the most frequently reported trigger, cited by roughly half of psoriasis patients as the initial cause of their disease and by over 70% as a flare trigger. Stress hormones like cortisol can directly influence inflammatory pathways that worsen psoriasis. Chronic stress that meets criteria for an anxiety disorder is worth discussing with your doctor.

Infections — particularly streptococcal pharyngitis (strep throat) — are a well-established trigger, especially for guttate psoriasis. Upper respiratory infections and skin infections can also provoke flares.

Medications that can trigger or worsen psoriasis include lithium, beta-blockers, antimalarials, ACE inhibitors, and NSAIDs. Abrupt withdrawal of systemic corticosteroids is a particularly dangerous trigger that can precipitate severe flares, including erythrodermic psoriasis.

Skin trauma — cuts, scrapes, sunburns, or even tattoos — can provoke new psoriasis plaques at the injury site, a phenomenon known as the Koebner response.

Lifestyle factors including smoking, heavy alcohol use, and obesity are associated with both increased risk of developing psoriasis and worse disease severity. Obesity in particular drives systemic inflammation and reduces the effectiveness of treatments.

Weather and climate can affect psoriasis. Cold, dry weather tends to worsen symptoms, while moderate sun exposure often improves them — though sunburn can trigger a Koebner response.

How Psoriasis Is Diagnosed

Psoriasis is diagnosed clinically — meaning your doctor can typically identify it based on the appearance and location of the lesions, your medical history, and a physical examination. No blood test can confirm psoriasis. In ambiguous cases, a skin biopsy may be performed to rule out other conditions such as eczema, fungal infections, or skin cancer.

Your doctor will assess disease severity based on body surface area (BSA) involvement. According to the National Psoriasis Foundation classification, mild psoriasis covers less than 3% of the body (roughly the area of three palm-sized patches), moderate covers 3–10%, and severe covers more than 10%. However, psoriasis in high-impact areas — the face, hands, feet, or genitals — may warrant more aggressive treatment regardless of the total area involved.

A telehealth evaluation is often sufficient for an initial assessment. Your doctor can evaluate your skin via video, review your medical history, discuss triggers, and start treatment — all without an in-person visit.

Psoriasis Treatment in 2026

Treatment for psoriasis follows a stepwise approach based on disease severity. According to the 2023 AAFP guidelines, treatment strategies are similar for most forms of psoriasis and are based on body surface area involved, location, and impact on quality of life. The goal is not just to clear skin — it is to reduce systemic inflammation, protect against comorbidities, and improve your quality of life.

Topical Treatments: The Foundation for Mild to Moderate Disease

Topical corticosteroids are the first-line treatment for all forms of mild to moderate psoriatic skin disease. They are available in various potencies (from mild hydrocortisone to super-potent clobetasol) and formulations (creams, ointments, foams, solutions). Your family doctor can prescribe the right potency for the right body area — lower potency for the face and skin folds, higher potency for thick plaques on the elbows and knees.

Vitamin D analogues such as calcipotriene (calcipotriol) slow skin cell growth and are often combined with topical corticosteroids. A Cochrane review of 177 randomized controlled trials found that the combination of a corticosteroid and vitamin D analogue performed better than either agent alone.

Other topical options include tazarotene (a retinoid), coal tar preparations, and newer agents like tapinarof cream and roflumilast cream — topical aryl hydrocarbon receptor agonists and PDE4 inhibitors that offer steroid-free alternatives.

Emollients (moisturizers) are not just supportive — they reduce itching and burning, improve the effectiveness of other topical treatments, and help maintain the skin barrier. Thick, fragrance-free moisturizers applied immediately after bathing are a cornerstone of daily psoriasis care.

Phototherapy: When Topicals Are Not Enough

Narrowband UVB phototherapy is effective for plaque and guttate psoriasis that does not improve with topicals alone. It typically requires two to three sessions per week in a dermatologist's office. While phototherapy requires in-person visits, your family doctor can initiate the referral and coordinate this alongside your ongoing care.

Systemic Treatments: For Moderate to Severe Disease

When psoriasis covers more than 10% of the body, affects high-impact areas, or significantly impairs quality of life, systemic treatments are indicated.

Nonbiologic systemics include methotrexate (the most commonly prescribed oral systemic for psoriasis), apremilast (Otezla — notably FDA-approved even for mild disease), cyclosporine, and deucravacitinib (Sotyktu), a TYK2 inhibitor approved in 2022.

Biologic therapies represent the most targeted and effective treatments available. These engineered antibodies or fusion proteins block specific inflammatory cytokines — including TNF-alpha, IL-17, IL-23, and IL-12/23. Biologics like adalimumab (Humira), secukinumab (Cosentyx), ixekizumab (Taltz), guselkumab (Tremfya), and risankizumab (Skyrizi) have demonstrated the ability to achieve 90% or greater skin clearance (PASI 90) in clinical trials.

New in 2026: Icotrokinra (Icotyde)

In March 2026, the FDA approved icotrokinra (brand name Icotyde) — the first oral IL-23 receptor antagonist for moderate-to-severe plaque psoriasis. This is a significant milestone: for the first time, patients have access to a targeted oral therapy that works through the same IL-23 pathway as the most effective injectable biologics, but in a once-daily pill taken with water before breakfast. In the ICONIC-ADVANCE trials, approximately 70% of patients achieved clear or almost clear skin (IGA 0/1) at 16 weeks, with durable results through 52 weeks — outcomes that exceeded those of deucravacitinib. Adverse event rates were within 1.1% of placebo.

What Your Family Doctor Can Do

Here is something most psoriasis articles will not tell you: the majority of psoriasis cases — particularly mild to moderate disease — can be effectively managed by your family medicine physician without ever seeing a dermatologist. Studies consistently show that 65–80% of psoriasis patients in primary care are managed with topical therapy alone, without needing systemic medications.

Your family doctor can diagnose psoriasis clinically, prescribe first-line topical corticosteroids and vitamin D analogues, monitor treatment response, adjust medications, screen for psoriatic arthritis using validated tools like the PEST (Psoriasis Epidemiology Screening Tool), and — critically — screen for the comorbidities that dermatology-focused care often misses.

When does your family doctor refer to a dermatologist? Referral is appropriate when psoriasis covers more than 10% of the body, when topical treatments fail after an adequate trial, when pustular or erythrodermic psoriasis is present, when biologic therapy is being considered, or when the diagnosis is uncertain.

Psoriasis and Depression: Why Mental Health Screening Matters

This is one of the most underaddressed aspects of psoriasis care, and it is where your primary care doctor becomes essential.

Research shows that 35% of psoriasis patients screen positive for depression and 29% for anxiety. The relationship is bidirectional: psoriasis causes visible disfigurement that leads to stigma, social isolation, and emotional distress, while stress and depression can worsen psoriasis through inflammatory pathways.

At Trinity Family Medicine, mental health screening is not an afterthought — it is integrated into every visit. Your doctor can administer standardized screening tools like the PHQ-9 for depression and the GAD-7 for anxiety, identify symptoms early, and initiate treatment — whether that means medication, a referral for therapy, or both. A dermatologist is trained to treat your skin. Your family doctor is trained to treat you.

Diet, Lifestyle, and Natural Remedies: What the Evidence Actually Says

Patients searching for "psoriasis diet" deserve honest, evidence-based answers — not wellness-influencer hype. Here is what the current research supports:

If you are carrying excess weight and have psoriasis, a medical weight loss program may be one of the most impactful lifestyle interventions available. Related metabolic conditions worth screening for include prediabetes, high cholesterol, hypothyroidism, and iron deficiency anemia — all of which your primary care doctor can screen for at the same visit.

Managing Psoriasis Over Telehealth

The National Psoriasis Foundation's Telemedicine Task Force has published formal guidance supporting the use of telehealth for psoriasis management. Teledermatology can provide reliable clinical information through thorough history-taking, patient-provided photographs, and validated disease activity assessment tools.

Here is what a telehealth psoriasis visit can accomplish: initial evaluation and diagnosis (for most presentations), prescription of topical and oral medications, treatment adjustment based on your response, mental health screening and treatment, lifestyle counseling, psoriatic arthritis screening, and comorbidity monitoring (blood pressure, metabolic health, cholesterol).

Tips for a productive virtual psoriasis visit: Take clear, well-lit photographs of your skin before the visit. Include close-up images and wider shots showing the distribution. Note any new symptoms, triggers you have identified, and how your current treatment is working.

At Trinity Family Medicine, psoriasis evaluation and management visits start at $49.99 via secure video — no insurance required, no waiting weeks for a dermatology appointment. You can book online or call 817-932-4022.

When to See Your Doctor

You should schedule a visit — in person or via telehealth — if you notice persistent, scaly patches on your skin that do not improve with over-the-counter moisturizers. You should also seek care if your skin is cracking, bleeding, or causing significant discomfort, if you develop joint pain, stiffness, or swelling (possible psoriatic arthritis), if psoriasis is affecting your sleep, work, or emotional wellbeing, or if your current treatment is not controlling your symptoms.

Seek emergency care for widespread redness and skin shedding covering most of the body (possible erythrodermic psoriasis), pustules covering large areas with fever, or signs of severe infection at cracked skin sites.

Trinity Family Medicine offers telehealth visits across Texas for psoriasis evaluation, treatment, and ongoing management. You see the same board-certified physician every visit, and appointments start at $49.99. Book online or call 817-932-4022.

Frequently Asked Questions

Key Takeaways

References